Direct inhibition of CSE1L by gene knockdown or inhibition of HDAC1/2 by mocetinostat treatment activated RB-DREAM and induced toxicity in p53 WT but not p53 mutant NSCLC cells. The gene discussed is HDAC1; the disease is non-small cell lung carcinoma.